Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Shares Outstanding 2010-2024 | HYPMY

Hypermarcas shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Hypermarcas Annual Shares Outstanding
(Millions of Shares)
2023 638
2022 639
2021 640
2020 638
2019 640
2018 639
2017 631
2016 631
2015 644
2014 629
2013
2012 671
2011 607
2010 524
2009
Hypermarcas Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 628
2024-06-30 631
2024-03-31 627
2023-12-31 638
2023-09-30 638
2023-06-30 639
2023-03-31 639
2022-12-31 639
2022-09-30 639
2022-06-30 639
2022-03-31 636
2021-12-31 640
2021-09-30 643
2021-06-30 627
2021-03-31 636
2020-12-31 638
2020-09-30 636
2020-06-30 640
2020-03-31 640
2019-12-31 640
2019-09-30 636
2019-06-30 636
2019-03-31 630
2018-12-31 639
2018-09-30 640
2018-06-30 631
2018-03-31 638
2017-12-31 631
2017-09-30 633
2017-06-30 608
2017-03-31 642
2016-12-31 631
2016-09-30 632
2016-06-30 643
2016-03-31 644
2015-12-31 644
2015-09-30 628
2015-06-30 616
2015-03-31 648
2014-12-31 650
2014-09-30 632
2014-06-30 631
2014-03-31 616
2013-12-31
2013-09-30 617
2013-06-30 644
2013-03-31 626
2012-12-31 594
2012-09-30 622
2012-06-30 743
2012-03-31 510
2011-12-31
2011-09-30 635
2011-06-30
2011-03-31 165
2010-12-31 549
2010-09-30
2010-06-30 533
2010-03-31
2009-12-31
2009-09-30 223
2009-06-30 199
2009-03-31 199
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.926B $1.585B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.797B 29.55
Chugai Pharmaceutical (CHGCY) Japan $66.907B 26.06
Takeda Pharmaceutical (TAK) Japan $42.351B 8.81
Sandoz Group AG (SDZNY) Switzerland $20.614B 0.00
Merck (MKKGY) Germany $20.007B 17.92
Astellas Pharma (ALPMY) Japan $17.699B 16.30
United Therapeutics (UTHR) United States $16.641B 16.37
Summit Therapeutics (SMMT) United States $15.958B 0.00
Neurocrine Biosciences (NBIX) United States $15.256B 40.40
Shionogi (SGIOY) Japan $12.454B 12.48
Orion OYJ (ORINY) Finland $7.529B 21.17
Madrigal Pharmaceuticals (MDGL) United States $7.117B 0.00
Stevanato Group S.p.A (STVN) Italy $6.493B 42.04
Corcept Therapeutics (CORT) United States $6.447B 48.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.192B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.937B 7.84
Grifols, S.A (GRFS) Spain $4.813B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.652B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.858B 12.95
Recursion Pharmaceuticals (RXRX) United States $2.798B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.705B 16.17
Centessa Pharmaceuticals (CNTA) United Kingdom $2.236B 0.00
Soleno Therapeutics (SLNO) United States $2.128B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.920B 0.00
Indivior (INDV) United States $1.675B 6.83
BioCryst Pharmaceuticals (BCRX) United States $1.661B 0.00
Evotec AG (EVO) Germany $1.495B 0.00
Guardian Pharmacy Services (GRDN) United States $1.413B 0.00
ARS Pharmaceuticals (SPRY) United States $1.392B 0.00
Dyne Therapeutics (DYN) United States $1.378B 0.00
Xencor (XNCR) United States $1.318B 0.00
Ardelyx (ARDX) United States $1.298B 0.00
Ocular Therapeutix (OCUL) United States $1.233B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.165B 0.00
Harrow (HROW) United States $1.152B 0.00
Collegium Pharmaceutical (COLL) United States $1.046B 5.71
Enliven Therapeutics (ELVN) United States $1.019B 0.00
Bioventus (BVS) United States $0.851B 26.90
Relay Therapeutics (RLAY) United States $0.750B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.738B 0.00
Cronos Group (CRON) Canada $0.719B 0.00
USANA Health Sciences (USNA) United States $0.662B 12.27
Verve Therapeutics (VERV) United States $0.652B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.595B 0.00
Xeris Biopharma Holdings (XERS) United States $0.544B 0.00
Akebia Therapeutics (AKBA) United States $0.502B 0.00
Elite Pharmaceuticals (ELTP) United States $0.500B 0.00
Altimmune (ALT) United States $0.494B 0.00
Organogenesis (ORGO) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.474B 0.00
ProKidney (PROK) United States $0.467B 0.00
Savara (SVRA) United States $0.458B 0.00
OmniAb (OABI) United States $0.448B 0.00
Siga Technologies (SIGA) United States $0.447B 5.22
KalVista Pharmaceuticals (KALV) United States $0.433B 0.00
Oruka Therapeutics (ORKA) United States $0.422B 0.00
Zevra Therapeutics (ZVRA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.419B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.396B 160.64
Esperion Therapeutics (ESPR) United States $0.372B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Aldeyra Therapeutics (ALDX) United States $0.308B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.277B 16.46
CytoDyn (CYDY) United States $0.255B 0.00
Heron Therapeutics (HRTX) United States $0.254B 0.00
Avita Medical (RCEL) United States $0.246B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.237B 0.00
Larimar Therapeutics (LRMR) United States $0.237B 0.00
4D Molecular Therapeutics (FDMT) United States $0.231B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Inhibikase Therapeutics (IKT) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Acrivon Therapeutics (ACRV) United States $0.173B 0.00
Lexeo Therapeutics (LXEO) United States $0.172B 0.00
Lyell Immunopharma (LYEL) United States $0.169B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.165B 0.00
Nanobiotix S.A (NBTX) France $0.163B 0.00
Silence Therapeutics (SLN) United Kingdom $0.157B 0.00
Nektar Therapeutics (NKTR) United States $0.154B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
Telomir Pharmaceuticals (TELO) United States $0.134B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.117B 0.00
Inotiv (NOTV) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.111B 0.00
Achieve Life Sciences (ACHV) Canada $0.111B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.106B 0.00
ElectroCore (ECOR) United States $0.104B 0.00
Metagenomi (MGX) United States $0.099B 0.00
Fractyl Health (GUTS) United States $0.097B 0.00
Protara Therapeutics (TARA) United States $0.093B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Journey Medical (DERM) United States $0.082B 0.00
AleAnna (ANNA) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.079B 20.75
Avalo Therapeutics (AVTX) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Century Therapeutics (IPSC) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Regulus Therapeutics (RGLS) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
AlloVir (ALVR) United States $0.049B 0.00
FibroGen (FGEN) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 0.00
BioVie (BIVI) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Traws Pharma (TRAW) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Mannatech (MTEX) United States $0.023B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
BioLineRx (BLRX) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00